Her predecessor, Dr. Märta Segerdahl, will continue to focus on her role as CMO of AlzeCure.

”I look forward to the strengthening of our development organization that Cecilia’s appointment will bring. Cecilia has extensive experience in all phases of drug development and many years of experience in leadership roles,” says Märta Segerdahl, CMO.

Cecilia Wadell

Cecilia Wadell has more than 25 years of industry experience with senior positions at both major pharmaceutical companies and smaller biotech companies, e.g. AstraZeneca, Wilson Therapeutics, Medivir and World Wide Clinical Trials.

”I am excited to join AlzeCure at such an exciting time in the company’s development. I hope to use my many years of clinical experience in clinical drug development to take AlzeCure’s drug candidates to the next level,” says Cecilia Wadell.